>
Floating Energy Assets Explained
What if Iran's next move against Washington is not a missile launch, but a convoy of oil tankers
Artificial Intelligence Could Transform Bank Runs From Hours-Long Crises...
Dubai Just Finished the World's First Permanent Air Taxi Route: Airport to the Marina in Under 1
Doroni Aerospace Raises More than $60m for H1?X Development
After 13 Years Battling Cancer, a 61-Year-Old Brazilian Man Achieved Complete Remission...
Extraterrestrial habitats may rise via Legos of laser-fused moon dust
Battery-only 19-seater puts China in the electric airliner race
Dream Chaser space plane gets landing approval for debut mission in 2027
SpaceX Just Caught Starship on Its FIRST Attempt!
Solid-State Cells Can Make The U.S. Competitive In Batteries Again: CEO
Jetson ONE personal eVTOL pod is about to go full sky patrol
America's INSANE BREAKTHROUGH Could Replace Septic Tanks Forever

Many patients with prostate cancer are treated with drugs to which they quickly develop resistance.
Now, a new study from Washington University School of Medicine in St. Louis has identified an RNA molecule that suppresses prostate tumors.
The scientists found that prostate cancers develop ways to shut down this RNA molecule to allow themselves to grow. However, when they implanted mice with human prostate tumor samples, the new treatment restored this so-called long noncoding RNA—and they've hailed it as a new strategy to treat the cancer which has developed resistance to hormonal therapies.